Prostate PIONEER

@ProstatePioneer

The European Network of Excellence for Big Data in Prostate Cancer

Arnhem, The Netherlands
prostate-pioneer.eu
Joined May 2018
350 Photos and videos Photos and videos

Tweets

You blocked @ProstatePioneer

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @ProstatePioneer

  1. Nov 16

    The Cancer Society of Finland will participate in the PIONEER consortium providing results from its Finnish Randomized Study of Screening. This brings the total number of datasets in the PIONEER platform to 15 with 10 currently being OMOP mapped.

    5 retweets 11 likes
    Undo
  2. Nov 14

    ✅ The abstract submission for Amsterdam is closed. So far, The PIONEER StudyAThon teams have submitted four abstracts, six abstracts were submitted by other PIONEER consortium members. ✅

    1 reply 2 retweets 15 likes
    Undo
  3. Nov 11

    Interested in a summary of the studyathon lightning talk at the symposium? Check out our latest newsletter issue: .

    3 retweets 7 likes
    Undo
  4. Nov 10

    PIONEER profits from the medicine Research data Repository (STARR-OMOP-deID) database. It includes data from approximately 7,158 unique patients of all stages, collected since 2005. More info: .

    2 retweets 5 likes
    Undo
  5. Nov 9

    In celebration of , PIONEER partner Radboud university medical center organised a fundraiser to support research and PIONEER. Thank you so much, ! We are delighted.

    2 retweets 5 likes
    Undo
  6. Nov 2

    Patient-reported outcome measures (PROMs) ask patients to assess their own health, quality of life, and functioning. The results can show how treatments affect a person’s everyday life. Help PIONEER to assess the validity of PROMs with this 3 min. survey: .

    6 retweets 10 likes
    Undo
  7. Oct 31

    "Improving the quality of cancer care for this and future generations": In the latest episode of the "Voice of EHDEN" podcast by , PIONEER coordinator talks about the study-a-thon experience and its impact.

    5 retweets 15 likes
    Undo
  8. Oct 28

    PIONEER research question 5: Which specific patient groups benefit most of upfront ? What are the side effects and What is the impact on quality of life in real-life?

    3 retweets 5 likes
    Undo
  9. Oct 26

    We are happy to announce that the data migration process to the new data platform at the Helmholtz-Zentrum Dresden-Rossendorf is progressing well and will soon be completed. More info will follow soon.

    3 retweets 7 likes
    Undo
  10. Oct 26

    Two days ago, American actor James Michael Tyler (“Friends") died. He was first diagnosed with stage 4 prostate cancer in 2018. Tyler, who was a supporter of the Prostate Cancer Foundation , had left a powerful video message in June 2021: .

    1 reply 6 retweets 19 likes
    Undo
  11. Oct 24

    PIONEER research question 4: When should we treat patients, who experience prostate cancer recurrence and which are the most effective therapeutic approaches?

    4 retweets 6 likes
    Undo
  12. Oct 21

    The Prostate Cancer Foundation supports research with the PCF Challenge Award. This year's award goes to Franklin Huang, Elisabeth Heath and Clayton Yates. 🎉Congrats, !

    4 retweets 8 likes
    Undo
  13. Oct 19

    PIONEER research question 3: What differentiates patients with lethal vs non-lethal disease, irrespective of their risk stratification? Just one of the prioritised questions being tackled by the consortium.

    2 retweets 8 likes
    Undo
  14. Oct 17

    Save the date: The next congress will take place on 18-21 March 2022 in Amsterdam - live! It will be the first in-person annual congress since EAU19 in Barcelona. ❗ Call for abstracts: deadline 1 November 2021 ❗

    2 retweets 9 likes
    Undo
  15. Oct 14

    PIONEER research question 2: What is the natural history of patients undergoing conservative management (i.e., watchful waiting) and what is the impact of comorbidities and life expectancy on long-term outcomes?

    3 retweets 4 likes
    Undo
  16. Oct 12

    We wish the new project every success as they launch 🎉 From PIONEER we look forward to future collaborations between the projects for improved cancer care

    Today is the official launch of OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence)! 🔍 36 partners 🔍 3 countries 🔍 budget: € 21.3 million Press release out now: .
    1 reply 6 retweets 11 likes
    Undo
  17. Retweeted
    Oct 7

    . is involved in . Now in his 11th year after being given 2 years to live, he credits his survival to a clinical trial. He also says the study-a-thon is one of the most exciting things he's ever done

    1 reply 6 retweets 20 likes
    Undo
  18. Oct 10

    PIONEER research question 1: What are the relevant tumour-specific and patient-specific variables that affect prognosis of prostate cancer patients suitable for active surveillance? For all the latest updates:

    2 retweets 3 likes
    Undo
  19. Oct 7

    The 9th Global Congress on takes place on 12 - 13 October 2021 in Ghent (Belgium). It will be streamed online, too. Scientific programme: .

    7 retweets 13 likes
    Undo
  20. Oct 5

    New to our page? PIONEER is a public−private partnership for in , working with >100 partners, including , to conduct research across the disease. Visit our website to learn more:

    4 retweets 9 likes
    Undo

@ProstatePioneer hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·